Viz.ai gets FDA nod for cardiomyopathy algorithm

Artificial intelligence (AI) software developer Viz.ai has secured de novo approva...Read more on AuntMinnie.comRelated Reading: Viz.ai nets FDA nod for AAA detection algorithm Viz.ai to use recruiting platform for pulmonary embolism trial Viz.ai inks deal with Bristol Meyers to deploy AI Viz.ai teams up with Johns Hopkins Viz.ai, TeleSpecialists tout study presented at ISC
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news